Letter to the Editor: PDF OnlyClinical Impact, Reactogenicity, and Immunogenicity After the First CoronaVac Dose in Kidney Transplant RecipientsMedina-Pestana, José PhD1; Cristelli, Marina Pontello PhD1; Viana, Laila Almeida MD1; Foresto, Renato Demarchi MD1; Requião-Moura, Lucio R. PhD1; Tedesco-Silva, Helio PhD1; Covas, Dimas Tadeu PhD2,3Author Information 1 Nephrology Division, Hospital do Rim, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. 2 Instituto Butantan, São Paulo, Brazil. 3 Center for Cell-based Therapy (CTC), Regional Blood Center of Ribeirão Preto, University of São Paulo, São Paulo, Brazil. Funding: No funding Disclosure: The authors of this manuscript have no conflicts of interest to disclose as described by the American Journal of Transplantation. Corresponding author: Marina Pontello Cristelli Nephrology Division, Hospital do Rim, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. Postal address: Borges Lagoa, 960, São Paulo, Brazil 04038-002 E-mail address: [email protected] Telephone number: +551155768000 Transplantation: July 20, 2021 - Volume - Issue - doi: 10.1097/TP.0000000000003901 Free PAP Metrics Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.